Four generations of ophthalmologists from Qin Nai established a $ 1.5 billion eye health care business

Mumbai: In 1994, the Agarwal family launched BleakDr. Agarwal’s Ophthalm Hospital of Ophthalmology (IPO) at 40 million times in Tamil Nadang is expanded. Thirty years later, the family initiated BleakNext week’s holding company’s 302.7 billion IPO, this will pay attention to the $ 1.5 billion of these two entities ( Bleak128.1 billion). This will make the Agarwal family (after IPO) has more than 32 % of its business, which will be one of India’s largest £ 1 million nursing, holding about $ 500 million in shares.

According to Dr. Amarwal’s respect, Dr. Agarwal’s Healthcare Co., Ltd. is India’s largest eye care chain store, which is based on the number of income and facilities. The company will start its IPO on January 29, 2025. This is a mix of a new problem Bleak3 billion rupees (OFS) up to 678 million shares, summarized to BleakBring 3,27.26 million on the top.

After listing, the sponsor will have about 32.5 % of the shares in the entity. Private equity companies TPG and TEMAAREK will sell most of the small shares of small shares from Agarwals.

Dr. Jaiveer Agarwal and his wife, Dr. Tahira Agarwal in 1957, started in 1957 in 1957. His son and current chairman Dr. Agarwal and four grandsons have expanded about two about 209 facilities so far so far to date So far, the entire India and Africa. (Dr. Jaiveer’s father is also an ophthalmologist, but did not participate in the establishment of an eye care business).

The subsidiary first lists

The company first listed the expansion of its subsidiary-Tamilnadbon on the Mumbai Stock Exchange (BSE) in 1994. Dr. Agrwal, CEO of the company’s chief executive officer, told Mint that we want to create a structure that enables them to export … Through this (listed) vehicles, this will be very difficult. He added: “Using the right consultant and consultant, we have established this holding company … All extensions other than Tamil Nadebon have occurred in the holding company.

He said that the family plan merged two entities in the next 12 months.

Dr. AMARARWAL (65 years old) and his son-Dr. Adil Agarwal, CEO of the Company, Dr. Anosh Agarwal, Chief Operating Officer, Dr. Asharwalwal, Chief Business Officer, Dr. Ashar Agarwal, Chief Clinic, Dr. L Except for family companies, all ophthalmologists have passed training. Advanced Agarwal also ensured that his son obtained a management degree to carry out business. Dr. Adil Agarwal obtained MBA from Stanford University Business School. Dr. Anosh Agarwal had a MBA degree from the Harvard Business College, and Dr. Ashar Agarwal also obtained a similar degree from the Kellog School of Management.

They are also the fourth -generation Agarwal family in Mint in an interview. Dr. Adil Agarwal was joking: “From six months, we have been told that this is what we must be … even without a doctor, we were told to be an ophthalmologist.”

Promise

The family’s commitment to eye health is being rewarded. India’s eye health service industry, value BleakThe hospital chain store said in the IPO media introduction that the compound annual growth rate between US $ 3780 billion in fiscal year in fiscal year was 12-14 % between fiscal and fiscal year. This is the fastest growing market segment in the field of special healthcare.

Dr. Agarwal has a market share of 25 % in the organized eye health market and is 1.7 times that of its next competitor ASG Hospital. Dr. Adil told Dr. Mint that it is increasingly increasingly growing in India ’s eye -care service market that is growing cataract surgery and lifestyle (such as diabetes or spending hours on the screen) and requires cure surgery.

“Another part is cosmetics … Like osteophytes, Botox surgery (for wrinkles around the eyes or crow’s feet wrinkles) … This is another growing part,” said Dr. Amar Agarwal. However, these segments have not made a significant contribution to the company’s income. Surgery involves cataract.

The focus of a single characteristic chain store like Dr. Agarwal is to retain doctors. Dr. Agarwal said: “This is your way of growth-your doctor is developing their brand, this is the development of your growth.”

For the eye care chain, seizing its main doctor is not a challenge-the loss rate of the promoter is less than 2 %. They added that the promoters’ families and managers themselves are the doctors themselves. Dr. Agarwal currently has 737 doctors and 1,624 assistants in its facilities in India and Africa.

The company is expanding rapidly in India, which brings more than 90 % of their income. It opened 45 centers in the 24th fiscal year, 30 centers in the first half of the 25th fiscal year, and planned to continue the expansion of Grimfield and Branfield. The company’s red catfish prospectus states that some of the income raised from new issues will be used to fund inorganic expansion.

When asked if the next generation of the Agarwal family (seven grandson 16 to 2 years old) also became an ophthalmologist to promote the current family heritage, Dr. AMAR said: “We want them to do a good job, what may mean. “